Teenage Transitions

Hosted by Nancy Hanna and Dena Gottesman

The guest on this episode has an ongoing commercial relationship with Insulet, and Insulet has paid a fee for their participation in this podcast.

Insulet and Beyond the Bolus are back at the ADA Scientific Sessions. Nancy Hanna, Clinical Services Manager at Insulet, is joined by Dr. Anita Swamy for a special live podcast, recording at the Omnipod booth in San Diego. Join them on a truly enlightening journey into the world of diabetes management as seen through the lens of the latest technology.

The Omnipod 5 system offers an optimistic approach towards alleviating the daily challenges associated with managing diabetes. Dr. Swamy is a stalwart in diabetes management, and she delivers a masterclass for the listeners on integrating technology into patient care. Dr. Swamy presents in-depth knowledge of both types of diabetes and their unique needs. She pinpoints how innovative methods such as the Automated Insulin Delivery (AID) can result in a marked improvement in patient care while minimizing disease management-associated stress.

Furthermore, the episode addresses low-resource demographics' ability to utilize such technology, breaking common misconceptions. Additionally, with a keen focus on patients transitioning from pediatrics to adult care, Dr. Swamy shares strategies to empower these patients in managing their disease independently.

Time stamps

4:04 – Who is a good candidate for automated insulin delivery?
7:01 – How do you transition young adults to start managing their own diabetes?
14:23 – Preparing young adults with type 1 diabetes for driving and college 
27:35 – Using technology to manage diabetes between visits

 

See more episodes
This podcast provides general information and discussions about health and related subjects. This information and other content provided in this podcast, or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. If you or any other person has a medical concern, you should consult your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that you have heard in this podcast or read in any linked materials. The opinions and views expressed on this podcast and website have no relation to those of any academic, hospital, health practice or other institution.

Please consult the Omnipod® 5 Automated Insulin Delivery System User Guide for more information.

The Omnipod 5 Automated Insulin Delivery System is a single hormone insulin delivery system intended to deliver U-100 insulin subcutaneously for the management of type 1 diabetes in persons aged 2 and older & type 2 diabetes in persons aged 18 years and older. The Omnipod 5 System is intended for single patient use. The Omnipod 5 System is indicated for use with NovoLog®, Humalog®, and Admelog®. Refer to the Omnipod 5 Automated Insulin Delivery System User Guide and www.omnipod.com/safety for complete safety information including indications, contraindications, warnings, cautions, and instructions. Warning: DO NOT use SmartAdjust technology for individuals under 2 years of age or use less than 5 U of insulin per day. DO NOT start to use the Omnipod 5 System or change settings without adequate training and guidance from a healthcare provider. Initiating and adjusting settings incorrectly can result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.